Literature DB >> 9551056

Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR).

J S Lindholt1, L Ostergård, E W Henneberg, H Fasting, P Andersen.   

Abstract

OBJECTIVE: To investigate whether Chlamydia pneumoniae is present in symptomatic abdominal aortic aneurysms (AAA). METHOD AND MATERIALS: After optimisation of DNA extraction procedures an inhibitor-controlled nested polymerase chain reaction (PCR) amplifying fragments of the gene encoding the C. pneumoniae specific major outer membrane protein was performed on 124 wall-specimens from 20 patients with symptomatic AAA.
RESULTS: None of the specimens contained C. pneumoniae-specific DNA. Minor inhibition of the PCR was noticed especially in media specimens.
CONCLUSION: Using a sensitive and specific nested PCR, we were not able to detect C. pneumoniae in symptomatic AAA. The failure to detect C. pneumoniae in symptomatic AAA, combined with previously reported positive findings in atherosclerotic lesions, supports the hypothesis that AAA and atherosclerosis might be two different disease entities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551056     DOI: 10.1016/s1078-5884(98)80138-x

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  15 in total

Review 1.  Molecular diagnosis of Chlamydia pneumoniae infection.

Authors:  J Boman; C A Gaydos; T C Quinn
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 2.  Chlamydia pneumoniae and atherosclerosis.

Authors:  J D Rutherford
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 3.  Microorganisms in the aetiology of atherosclerosis.

Authors:  S A Morré; W Stooker; W K Lagrand; A J van den Brule; H W Niessen
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

Review 4.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

5.  Comments on the failure to detect Chlamydia pneumoniae in atherosclerosis.

Authors:  D Taylor-Robinson; J Boman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-23       Impact factor: 3.267

6.  Failure to detect Chlamydia pneumoniae by cell culture and polymerase chain reaction in major arteries of 93 patients with atherosclerosis.

Authors:  J Bishara; S Pitlik; A Kazakov; G Sahar; M Haddad; A Vojdani; S Rosenberg; Z Samra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-09       Impact factor: 3.267

7.  PCR detection and molecular identification of Chlamydiaceae species.

Authors:  J C Hartley; S Kaye; S Stevenson; J Bennett; G Ridgway
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

8.  Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions.

Authors:  A Meijer; P J Roholl; S K Gielis-Proper; J M Ossewaarde
Journal:  J Clin Pathol       Date:  2000-12       Impact factor: 3.411

9.  Immunohistostaining assays for detection of Chlamydia pneumoniae in atherosclerotic arteries indicate cross-reactions with nonchlamydial plaque constituents.

Authors:  Vicky Y Hoymans; Johan M Bosmans; Dominique Ursi; Wim Martinet; Floris L Wuyts; Eric Van Marck; Martin Altwegg; Christiaan J Vrints; Margareta M Ieven
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

Review 10.  Failure to detect Chlamydia pneumoniae DNA in cerebral aneurysmal sac tissue with two different polymerase chain reaction methods.

Authors:  S Cagli; N Oktar; T Dalbasti; S Erensoy; N Ozdamar; S Göksel; A Sayiner; A Bilgiç
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.